A carregar...

Molecular basis of pharmacotherapies for cognition in Down syndrome

Intellectual disability (ID) in Down syndrome (DS) ranges from low normal to severely impaired, and has a significant impact on the quality of life of the individuals affected and their families. Because the incidence of DS remains at approximately one in 700 live births and the life span is now >...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Autor principal: Gardiner, Katheleen J.
Formato: Artigo
Idioma:Inglês
Publicado em: 2009
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2815198/
https://ncbi.nlm.nih.gov/pubmed/19963286
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tips.2009.10.010
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!